Insider · CIK 0001174533

DEMANE MICHAEL F

Reports to the SEC for 2 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001174533

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-04-03	NEVRO CORPD Disposition to Issuer	Director	DDisposition to Issuer	−164K sh	—	—	0
2025-04-03	NEVRO CORPD Disposition to Issuer	Director	DDisposition to Issuer	−219K sh	—	—	0
2025-04-03	NEVRO CORPD Disposition to Issuer	Director	DDisposition to Issuer	−58.3K sh	—	—	0
2025-04-03	NEVRO CORPD Disposition to Issuer	Director	DDisposition to Issuer	−61.9K sh	—	—	0
2024-12-31	NEVRO CORPA Award	Director	AAward	+7,056 sh	—	—	61,863
2024-09-30	NEVRO CORPA Award	Director	AAward	+4,695 sh	—	—	54,807
2024-06-30	NEVRO CORPA Award	Director	AAward	+3,117 sh	—	—	50,112
2024-05-23	NEVRO CORPA Award	Director	AAward	+19.2K sh	—	—	46,995
2024-03-31	NEVRO CORPA Award	Director	AAward	+1,817 sh	—	—	33,205
2023-12-31	NEVRO CORPA Award	Director	AAward	+1,219 sh	—	—	31,388
2023-09-30	NEVRO CORPA Award	Director	AAward	+1,365 sh	—	—	30,169
2023-06-30	NEVRO CORPA Award	Director	AAward	+1,032 sh	—	—	28,804
2023-06-07	NEVRO CORPG Gift	Director	GGift	−80K sh	—	—	27,772
2023-05-25	NEVRO CORPA Award	Director	AAward	+6,754 sh	—	—	107,772
2023-04-12	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−80.3K sh	—	—	0
2023-04-12	NEVRO CORPM Exercise/Conversion	Director	MExercise/Conversion	+80.3K sh	$18.00	+$1.45M	101,018
2023-03-31	NEVRO CORPA Award	Director	AAward	+726 sh	—	—	20,727
2022-12-30	NEVRO CORPA Award	Director	AAward	+662 sh	—	—	20,001
2022-09-30	NEVRO CORPA Award	Director	AAward	+563 sh	—	—	19,339
2022-06-30	NEVRO CORPA Award	Director	AAward	+598 sh	—	—	44,900
2022-05-26	NEVRO CORPA Award	Director	AAward	+4,155 sh	—	—	44,302
2022-03-31	NEVRO CORPA Award	Director	AAward	+362 sh	—	—	40,147
2021-12-31	NEVRO CORPA Award	Director	AAward	+323 sh	—	—	44,433
2021-09-30	NEVRO CORPA Award	Director	AAward	+225 sh	—	—	231,660
2021-06-30	NEVRO CORPA Award	Director	AAward	+158 sh	—	—	231,435
2021-06-22	NEVRO CORPS Sale	Director	SSale	−6,445 sh	$179.03	−$1.15M	231,277
2021-05-25	NEVRO CORPA Award	Director	AAward	+1,167 sh	—	—	237,722
2021-03-31	NEVRO CORPA Award	Director	AAward	+188 sh	—	—	236,555
2020-12-31	NEVRO CORPA Award	Director	AAward	+160 sh	—	—	236,367
2020-10-12	NEVRO CORPS Sale	Director	SSale	−200 sh	$151.62	−$30.3K	236,207
2020-10-12	NEVRO CORPS Sale	Director	SSale	−703 sh	$151.09	−$106K	236,407
2020-10-09	NEVRO CORPS Sale	Director	SSale	−20.5K sh	$150.31	−$3.09M	237,110
2020-09-30	NEVRO CORPA Award	Director	AAward	+199 sh	—	—	257,639
2020-09-16	NEVRO CORPS Sale	Director	SSale	−5,002 sh	$145.53	−$728K	268,466
2020-09-16	NEVRO CORPS Sale	Director	SSale	−4,169 sh	$147.41	−$615K	258,320
2020-09-16	NEVRO CORPS Sale	Director	SSale	−880 sh	$148.19	−$130K	257,440
2020-09-16	NEVRO CORPS Sale	Director	SSale	−5,977 sh	$146.59	−$876K	262,489
2020-09-15	NEVRO CORPS Sale	Director	SSale	−2,000 sh	$145.27	−$291K	273,468
2020-09-02	NEVRO CORPS Sale	Director	SSale	−3,400 sh	$145.25	−$494K	275,468
2020-08-27	NEVRO CORPS Sale	Director	SSale	−8,081 sh	$140.55	−$1.14M	289,687
2020-08-27	NEVRO CORPS Sale	Director	SSale	−10.8K sh	$141.34	−$1.53M	278,868
2020-08-13	NEVRO CORPS Sale	Director	SSale	−300 sh	$140.05	−$42K	347,768
2020-08-10	NEVRO CORPS Sale	Director	SSale	−400 sh	$138.70	−$55.5K	38,054
2020-08-10	NEVRO CORPS Sale	Director	SSale	−1,626 sh	$134.42	−$219K	40,928
2020-08-10	NEVRO CORPS Sale	Director	SSale	−1,474 sh	$135.64	−$200K	39,454
2020-08-10	NEVRO CORPS Sale	Director	SSale	−30.5K sh	$134.34	−$4.09M	401,039
2020-08-10	NEVRO CORPS Sale	Director	SSale	−1,000 sh	$136.37	−$136K	38,454
2020-08-10	NEVRO CORPS Sale	Director	SSale	−24.2K sh	$136.18	−$3.3M	357,046
2020-08-10	NEVRO CORPS Sale	Director	SSale	−2,828 sh	$140.11	−$396K	348,068
2020-08-10	NEVRO CORPS Sale	Director	SSale	−19.8K sh	$135.58	−$2.68M	381,254

Recent filings

Accepted (ET)
Apr 34
DEMANE MICHAEL F0000950170-25-050470
SEC(opens sec.gov)
Jan 24
DEMANE MICHAEL F0001444380-25-000006
SEC(opens sec.gov)
Oct 24
DEMANE MICHAEL F0001610717-24-000498
SEC(opens sec.gov)
Jul 24
DEMANE MICHAEL F0001610717-24-000383
SEC(opens sec.gov)
May 284
DEMANE MICHAEL F0001610717-24-000261
SEC(opens sec.gov)
Apr 24
DEMANE MICHAEL F0001610717-24-000202
SEC(opens sec.gov)
Jan 34
DEMANE MICHAEL F0001610717-24-000002
SEC(opens sec.gov)
Oct 34
DEMANE MICHAEL F0001610717-23-000302
SEC(opens sec.gov)
Jul 54
DEMANE MICHAEL F0001610717-23-000199
SEC(opens sec.gov)
Jun 94
DEMANE MICHAEL F0001610717-23-000107
SEC(opens sec.gov)
May 304
DEMANE MICHAEL F0001610717-23-000081
SEC(opens sec.gov)
Apr 144
DEMANE MICHAEL F0001610717-23-000011
SEC(opens sec.gov)
Apr 44
DEMANE MICHAEL F0001140361-23-016281
SEC(opens sec.gov)
Jan 44
DEMANE MICHAEL F0001567619-23-000249
SEC(opens sec.gov)
Oct 44
DEMANE MICHAEL F0001567619-22-018224
SEC(opens sec.gov)
Jul 54
DEMANE MICHAEL F0001567619-22-013693
SEC(opens sec.gov)

Companies

Address

C/O NEVRO CORP. 4040 CAMPBELL AVENUE

MENLO PARK, CA, 94025